New treatment option for Cervicogenic Headache
Official title "Additional Effects of Sternocleidomastoid Release Along With Suboccipital Muscle Release in Management of Cervicogenic Headache'
ClinicalTrials.gov ID: NCT06731114
What this study is testing
- What it's testing
- This study is a randomised control trial and the purpose of this study is to determine the "Additional effects of sternocleidomastoid release along with suboccipital muscle release in management of cervicogenic headache".
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45
You may be able to join if
- Participants will be included according to international classification of headache criteria which includes:
- Headache with neck stiffness
- Headache at least once a month in the last 3 months
- Headache with at least 4 score in Numeric Pain Rating Scale(NPRS)
- Unilateral headache with no shift of side
You likely can't join if
- Cervical spondylosis
- Headache of non-cervical origin
- Dizziness or visual disturbance
- Cervical radiculopathy/ nerve root involvement/ disc herniation
- Cervical instability/ fracture
- Vertebrobasilar insufficiency
See the full eligibility criteria
- Participants will be included according to international classification of headache criteria which includes:
- Headache with neck stiffness
- Headache at least once a month in the last 3 months
- Headache with at least 4 score in Numeric Pain Rating Scale(NPRS)
- Unilateral headache with no shift of side
- Positive flexion rotation test (Rotation restriction is greater than 10 degrees)
- C1-C2 dysfunction
- Headache precipitated by sustained neck movements,myofacial trigger points palpation in neck
- Age group 18-45
- Both male and female
- Cervical spondylosis
- Headache of non-cervical origin
- Dizziness or visual disturbance
- Cervical radiculopathy/ nerve root involvement/ disc herniation
- Cervical instability/ fracture
- Vertebrobasilar insufficiency
- Thoracic outlet syndrome
- Cervical spine surgery
- Cervical spondylolisthesis
- Spinal infection or tumors
- Osteoporosis
- meningitis
- subarachnoid hemorrhage
The study team makes the final eligibility decision.
Where it's taking place
- Rawalpindi, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rawalpindi, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.